The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Warburg Pincus Partners Llc since year 2005.
The trader's CIK number is 1322709.
At the time of this reporting, Warburg Pincus Partners Llc is the Director of Sunesis Pharmaceuticals Inc .
(stock ticker symbol SNSS).
See this page for all insider trading activities at Sunesis Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2007-05-30||SNSS||Sunesis Pharmaceuticals Inc||Buy||677,200||4.43||2,999,996|
|2006-03-20||TDG||Transdigm Group Inc||Sale||821,594||21.00||17,253,474|
|2006-03-17||SNSS||Sunesis Pharmaceuticals Inc||Buy||805,153||6.21||5,000,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Warburg Pincus Partners Llc (Director of Sunesis Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.